Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher

Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed publisher

Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed

Kranz L, Diken M, Haas H, Kreiter S, Loquai C, Reuter K, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534:396-401 pubmed publisher

Sekine T, Perez Potti A, Rivera Ballesteros O, Stralin K, Gorin J, Olsson A, et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183:158-168.e14 pubmed publisher

Kordulewska N, Cieslińska A, Fiedorowicz E, Jarmołowska B, Piskorz Ogórek K, Kostyra E. Cytokines concentrations in serum samples from allergic children-Multiple analysis to define biomarkers for better diagnosis of allergic inflammatory process. Immunobiology. 2018;223:648-657 pubmed publisher

Sahin U, Derhovanessian E, Miller M, Kloke B, Simon P, Löwer M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547:222-226 pubmed publisher

Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher

Meng Q, Liu Z, Rangelova E, Poiret T, Ambati A, Rane L, et al. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer. J Immunother. 2016;39:81-9 pubmed publisher

Arakawa A, Siewert K, Stöhr J, Besgen P, Kim S, Rühl G, et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015;212:2203-12 pubmed publisher

Rahma O, Herrin V, Ibrahim R, Toubaji A, Bernstein S, Dakheel O, et al. Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer. J Transl Med. 2014;12:353 pubmed publisher

Rahma O, Hamilton J, Wojtowicz M, Dakheel O, Bernstein S, Liewehr D, et al. The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors. J Transl Med. 2014;12:55 pubmed publisher

Cannella A, Arlehamn C, Sidney J, Patra K, Torres K, Tsolis R, et al. Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru. Infect Immun. 2014;82:124-31 pubmed publisher

Met O, Svane I. Analysis of survivin-specific T cells in breast cancer patients using human DCs engineered with survivin mRNA. Methods Mol Biol. 2013;969:275-92 pubmed publisher

Wang X, Greenfield W, Coleman H, James L, Nakagawa M. Use of interferon-? enzyme-linked immunospot assay to characterize novel T-cell epitopes of human papillomavirus. J Vis Exp. 2012;: pubmed publisher

Snyder Cappione J, Tincati C, Eccles James I, Cappione A, Ndhlovu L, Koth L, et al. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-? and MIP1-?, a lack of IL-17, and a Th1-bias in males. PLoS ONE. 2010;5:e15412 pubmed publisher

Schreiber F, Huo Z, Giemza R, Woodrow M, Fenner N, Stephens Z, et al. An investigation of clinical and immunological events following repeated aerodigestive tract challenge infections with live Mycobacterium bovis Bacille Calmette Guérin. Vaccine. 2010;28:5427-31 pubmed publisher

Rakotosamimanana N, Raharimanga V, Andriamandimby S, Soares J, Doherty T, Ratsitorahina M, et al. Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin Vaccine Immunol. 2010;17:1094-103 pubmed publisher

Rahma O, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin V, et al. A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma. J Transl Med. 2010;8:8 pubmed publisher

Co M, Orphin L, Cruz J, Pazoles P, Green K, Potts J, et al. In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses. Vaccine. 2009;27:319-27 pubmed publisher

Lunemann J, Jelcic I, Roberts S, Lutterotti A, Tackenberg B, Martin R, et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med. 2008;205:1763-73 pubmed publisher

McCarthy C, Shepherd D, Fleire S, Stronge V, Koch M, Illarionov P, et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med. 2007;204:1131-44 pubmed

Currier J, Kuta E, Turk E, Earhart L, Loomis Price L, Janetzki S, et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods. 2002;260:157-72 pubmed